Sorafenib modulates the radio sensitivity of hepatocellular carcinoma cells in vitro in a schedule-dependent manner

BACKGROUND: Hepatocellular carcinoma (HCC) has a high incidence and mortality. Radiotherapy and sorafenib have proven effective for HCC. Here, we investigated whether sorafenib modulated the response of HCC cells to irradiation in vitro, effect of timing of sorafenib, and the underlying mechanisms....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qiaoqiao, Hu, Yonghong, Xi, Mian, He, Liru, Zhao, Lei, Liu, Mengzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488336/
https://www.ncbi.nlm.nih.gov/pubmed/23088517
http://dx.doi.org/10.1186/1471-2407-12-485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488336/
https://www.ncbi.nlm.nih.gov/pubmed/23088517
http://dx.doi.org/10.1186/1471-2407-12-485

Ejemplares similares